Kistler-Tiffany Companies’s Esperion Therapeutics ESPR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $139 | Hold |
100
| – | – | ﹤0.01% | 882 |
|
|
2023
Q1 | $159 | Hold |
100
| – | – | ﹤0.01% | 781 |
|
|
2022
Q4 | $623 | Hold |
100
| – | – | ﹤0.01% | 762 |
|
|
2022
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 752 |
|
|
2022
Q2 | $1K | Hold |
100
| – | – | ﹤0.01% | 735 |
|
|
2022
Q1 | $0 | Hold |
100
| – | – | ﹤0.01% | 759 |
|
|
2021
Q4 | $1K | Hold |
100
| – | – | ﹤0.01% | 698 |
|
|
2021
Q3 | $1K | Hold |
100
| – | – | ﹤0.01% | 695 |
|
|
2021
Q2 | $2K | Hold |
100
| – | – | ﹤0.01% | 662 |
|
|
2021
Q1 | $3K | Hold |
100
| – | – | ﹤0.01% | 592 |
|
|
2020
Q4 | $3K | Hold |
100
| – | – | ﹤0.01% | 573 |
|
|
2020
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 559 |
|
|
2020
Q2 | $5K | Hold |
100
| – | – | ﹤0.01% | 505 |
|
|
2020
Q1 | $6K | Hold |
100
| – | – | ﹤0.01% | 484 |
|
|
2019
Q4 | $6K | Hold |
100
| – | – | ﹤0.01% | 492 |
|
|
2019
Q3 | $4K | Hold |
100
| – | – | ﹤0.01% | 523 |
|
|
2019
Q2 | $5K | Buy |
+100
| New | +$5K | ﹤0.01% | 499 |
|
|
2018
Q2 | – | Sell |
-100
| Closed | -$7K | – | 576 |
|
|
2018
Q1 | $7K | Buy |
+100
| New | +$7K | ﹤0.01% | 458 |
|